Large-scale testing (Phase 3)Looking for participantsNCT06096116
What this trial is testing
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
Who this might be right for
Acquired Antithrombin Deficiency
Octapharma 120